We are live on
!
Find out more
NC
Nekton Capital Portfolio holdings
AUM
$49.4M
1-Year Est. Return
2.45%
This Fund
S&P 500
This Quarter
Est. Return
+2.13%
1 Year Est. Return
-2.45%
3 Year Est. Return
+30.15%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$599M
AUM Growth
+$156M
(+35%)
Cap. Flow
+$160M
Cap. Flow
% of AUM
26.63%
Top 10 Holdings %
Top 10 Hldgs %
79.53%
Holding
25
New
7
Increased
5
Reduced
1
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$67.4M |
| 2 |
Colgate-Palmolive
CL
|
+$50.9M |
| 3 |
NATI
National Instruments Corp
NATI
|
+$46.8M |
| 4 |
Union Pacific
UNP
|
+$40.6M |
| 5 |
Dollar General
DG
|
+$35.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$41M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$40.7M |
| 3 |
Electronic Arts
EA
|
+$27.1M |
| 4 |
UDR
UDR
|
+$18.9M |
| 5 |
Huazhu Hotels Group
HTHT
|
+$16.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.47% |
| 2 | Industrials | 17.83% |
| 3 | Financials | 15.79% |
| 4 | Consumer Staples | 14.08% |
| 5 | Technology | 12.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Qiagen
QGEN
$8.57B
| $81.9M | 13.66% |
1,681,371
| – | – |
|
|
2
Alcon
ALC
$33.8B
| $68.2M | 11.37% |
966,442
+946,856
| +4,834% | +$67.4M |
|
|
HZNP
3
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $56.5M | 9.43% |
517,755
+246,840
| +91% | +$27.3M |
|
|
4
Colgate-Palmolive
CL
$73.7B
| $51.4M | 8.58% |
+683,886
| New | +$50.9M |
|
|
NATI
5
DELISTED
National Instruments Corp
NATI
| $48.9M | 8.15% |
+932,419
| New | +$46.8M |
|
|
6
Union Pacific
UNP
$176B
| $40.3M | 6.72% |
+200,206
| New | +$40.6M |
|
7
Jacobs Solutions
J
$16.8B
| $36.9M | 6.15% |
379,445
+81,949
| +28% | +$8.18M |
|
|
8
Dollar General
DG
$28B
| $33M | 5.5% |
+156,671
| New | +$35.2M |
|
|
SJR
9
DELISTED
Shaw Communications Inc.
SJR
| $30M | 5% |
1,002,063
+247,169
| +33% | +$7.16M |
|
10
Emerson Electric
EMR
$87.4B
| $29.7M | 4.96% |
+340,996
| New | +$29.8M |
|
11
PTC
PTC
$16B
| $28M | 4.67% |
+218,474
| New | +$27.8M |
|
12
Brookfield Asset Management
BAM
$84.5B
| $26.7M | 4.46% |
817,174
+144,583
| +21% | +$4.7M |
|
|
BNY
13
Bank of New York Mellon
BNY
$107B
| $26.2M | 4.38% |
+577,350
| New | +$28M |
|
14
CME Group
CME
$94.7B
| $24.9M | 4.15% |
129,765
-30,840
| -19% | -$5.58M |
|
15
Brookfield
BN
$108B
| $16.8M | 2.81% |
774,956
| – | – |
|
16
Alnylam Pharmaceuticals
ALNY
$28.8B
| – | – |
-33,890
| Closed | -$8.05M |
|
17
BioMarin Pharmaceuticals
BMRN
$11.8B
| – | – |
-152,632
| Closed | -$15.8M |
|
|
18
Electronic Arts
EA
| – | – |
-221,542
| Closed | -$27.1M |
|
19
Expedia Group
EXPE
$37.1B
| – | – |
-184,443
| Closed | -$16.2M |
|
|
20
Alphabet (Google) Class A
GOOGL
$4.37T
| – | – |
-461,610
| Closed | -$40.7M |
|
|
21
Huazhu Hotels Group
HTHT
$13.2B
| – | – |
-397,345
| Closed | -$16.9M |
|
22
Otis Worldwide
OTIS
$28B
| – | – |
-179,529
| Closed | -$14.1M |
|
|
23
UDR
UDR
$12.2B
| – | – |
-488,754
| Closed | -$18.9M |
|
|
24
Zimmer Biomet
ZBH
$18.7B
| – | – |
-321,625
| Closed | -$41M |
|
|
LAC
25
DELISTED
Lithium Americas Corp. Common Shares
LAC
| – | – |
-516,021
| Closed | -$9.78M |
|
Similar funds
ECT
VSAM
RPM
E
IPI
CIEP
ST
WAMC
Nekton Capital's Q1 2023 Portfolio in Review
As of Q1 2023, Nekton Capital held 25 positions worth $599M, up 35% from $443M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Nekton Capital deployed $160M of net new capital in Q1 2023, opening 7 new positions and adding to 5 existing holdings. Its largest new stake was Colgate-Palmolive: 683,886 shares worth $51.4M.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 42% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was CME Group, an estimated $5.58M trimmed.
- Nekton Capital's largest Q1 2023 buy was Colgate-Palmolive: 683,886 shares worth $51.4M.
- Nekton Capital added most to Alcon in Q1 2023, an estimated $67.4M increase.
- Nekton Capital's biggest Q1 2023 reduction was CME Group, cutting an estimated $5.58M.
- Nekton Capital fully exited Zimmer Biomet in Q1 2023, selling an estimated $41M.
- Nekton Capital's ten largest holdings make up 80% of its $599M portfolio in Q1 2023.
- Nekton Capital opened 7 new positions and closed 10 in Q1 2023.
- Nekton Capital's portfolio value rose 35% quarter-over-quarter to $599M.
Based on Nekton Capital's 13F filing for Q1 2023, filed 15 May 2023.